Krensavage Asset Management, LLC - Q3 2015 holdings

$276 Million is the total value of Krensavage Asset Management, LLC's 23 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 4.5% .

 Value Shares↓ Weighting
ENTA BuyENANTA PHARMACEUTICALS INC$26,393,000
-17.0%
730,308
+3.3%
9.55%
-20.4%
UTHR BuyUNITED THERAPEUTICS CORP$26,192,000
+1.2%
199,573
+34.1%
9.48%
-2.9%
BXLT NewBAXALTA INC$22,744,000721,800
+100.0%
8.23%
TEVA BuyTEVA PHARMACEUTICAL-SP ADR$21,063,000
+15.0%
373,062
+20.4%
7.62%
+10.3%
OFIX BuyORTHOFIX INTERNATIONAL NV$20,596,000
+18.8%
610,247
+16.6%
7.46%
+14.0%
IPXL BuyIMPAX LABORATORIES INC$18,695,000
-10.6%
530,875
+16.6%
6.77%
-14.2%
BuyINDIVIOR PLC$15,286,000
+0.2%
4,459,944
+3.3%
5.53%
-3.9%
HYH BuyHALYARD HEALTH INC$15,242,000
-13.7%
535,943
+22.9%
5.52%
-17.2%
BuyAMGEN INC$14,321,000
+35.0%
103,536
+49.9%
5.18%
+29.6%
CNMD BuyCONMED CORP$13,106,000
-15.3%
274,528
+3.4%
4.74%
-18.7%
MRK BuyMERCK & CO INC$12,323,000
-2.5%
249,503
+12.3%
4.46%
-6.5%
HRC BuyHILL-ROM HOLDINGS INC$10,695,000
-1.1%
205,713
+3.3%
3.87%
-5.1%
SCMP SellSUCAMPO PHARMACEUTICALS-CL A$10,495,000
-34.0%
528,175
-45.4%
3.80%
-36.6%
RTIX BuyRTI SURGICAL INC$10,387,000
-9.2%
1,828,672
+3.3%
3.76%
-12.8%
DEPO BuyDEPOMED INC$7,076,000
-9.1%
375,387
+3.4%
2.56%
-12.8%
AGN BuyALLERGAN PLC$6,589,000
-6.8%
24,240
+4.1%
2.38%
-10.5%
SPPI BuySPECTRUM PHARMACEUTICALS INC$6,449,000
+11.7%
1,078,502
+27.8%
2.33%
+7.2%
IVC BuyINVACARE CORP$5,822,000
-23.9%
402,382
+13.8%
2.11%
-27.0%
BuyBIOTA PHARMACEUTICALS INC$5,090,000
+50.1%
2,570,577
+56.9%
1.84%
+44.0%
JNP SellJUNIPER PHARMACEUTICALS INC$3,295,000
+9.9%
279,717
-14.6%
1.19%
+5.5%
DRAD BuyDIGIRAD CORP$1,712,000
-11.0%
457,699
+3.3%
0.62%
-14.5%
FURX  FURIEX PHARMACEUTICA CMN$1,422,0000.0%145,5440.0%0.52%
-3.9%
THRX BuyTHERAVANCE INC$1,264,000
-58.9%
176,108
+3.4%
0.46%
-60.5%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITED THERAPEUTICS CORP36Q3 202318.1%
Enanta Pharmceuticals Inc35Q3 202316.7%
INVACARE CORP28Q3 20215.8%
RTI SURGICAL INC23Q2 20207.9%
MCKESSON CORP20Q3 202216.3%
BIOGEN INC19Q3 202316.0%
MERCK & CO. INC.18Q1 201911.1%
DIGIRAD CORP18Q1 20191.0%
REGENERON PHARMACEUTICALS16Q3 202316.1%
ALKERMES PLC16Q3 202314.1%

View Krensavage Asset Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Krensavage Asset Management, LLC Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SURGALIGN HOLDINGS, INC.February 19, 20215,380,4496.6%
RTI SURGICAL, INC.February 14, 20193,852,5676.1%
Aviragen Therapeutics, Inc.February 15, 20182,292,0585.9%
ENANTA PHARMACEUTICALS INCFebruary 15, 2017883,9024.6%
Biota Pharmaceuticals, Inc.February 17, 20162,267,6555.9%

View Krensavage Asset Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SCHEDULE 13G2024-02-27
13F-HR2024-02-14
13F-HR2023-11-15
13F-HR2023-08-11
13F-HR2023-05-16
13F-HR2023-02-15
13F-HR2022-11-15
13F-HR2022-08-16
13F-HR2022-05-17
13F-HR2022-02-15

View Krensavage Asset Management, LLC's complete filings history.

Compare quarters

Export Krensavage Asset Management, LLC's holdings